Ashida H & Sasakawa C. Shigella IpaH family effectors as a versatile model for studying pathogenic bacteria. Front. Cell. Infect. Microbiol. 5. 100 (2016).
Ashida H., et al. Shigella manipulates host immune responses by delivering effector proteins with specific roles. Front. Immunol. 6, 219 (2015).
Ashida H., et al. Exploitation of the host ubiquitin system by human bacterial pathogens. Nature Review Microbiology 12, 399-413 (2014).
Ashida H & Sasakawa C. Shigella hacks host immune responses by reprogramming the host epigenome. EMBO Journal. 33, 2598-2600 (2014).
Ashida H., et al. Manipulation of the host cell death pathway by Shigella. Cellular Microbiology. 16, 1757-1766 (2014).
Ashida H., et al. Shigella IpaH0722 E3 ubiquitin ligase effector targets TRAF2 to inhibit PKC?NF-κB activity in invaded epithelial cells. PLos Pathogens. e1003409. (2013).
Ashida H., et al. Bacteria and host interactions in the gut epithelial barrier. Nature Chemical Biology. 8, 36-45 (2012).
Ashida H., et al. Cell death and infection: a double-edged sword for host and pathogen survival. Journal Cell Biology. 195, 931-42 (2011).
Ashida H., et al. Shigella are versatile mucosal pathogens that circumvent the host innate immune system. Curr. Opin. in Immunology. 23, 448-55 (2011).
Ashida H., et al. Shigella deploy multiple countermeasures against host innate immune responses. Curr. Opin. in Microbiol. 14, 16-23 (2011).
Ashida H., et al. A bacterial E3 ubiquitin ligase IpaH9.8 effector targets NEMO/IKKγ to dampen the host NF-κB-mediated inflammatory response. Nature Cell Biology. 12, 66-73 (2010).